Effect of adjuvant radiation therapy on mortality according to primary tumor location in women with node-positive breast cancer: Is there a need to irradiate the internal mammary nodes?
545 Background: This analysis evaluates the prognostic significance of primary tumor location and examines the question of whether the effect of adjuvant radiation therapy (RT) on survival varies according to tumor location in women with node-positive breast cancer. Methods: Data were abstracted from the Surveillance, Epidemiology, and End Results database for 24,410 women aged 25- 95 years, diagnosed between 1988–1997 with nonmetastatic T1-T2 axillary node-positive primary breast carcinoma. Subgroup analyses were performed using interactions within proportional hazards models in which the event was defined as death from any cause. Prognostic variables were selected using the Akaike Information Criteria. The joint significances of subgroups were evaluated with the Wald test. Results: The median follow-up time was 10 years. In joint models, statistically significant interactions were found between tumor location, nodal involvement, type of surgery, and RT use. A factorial presentation of these interactions showed a consistent 13% proportional reduction of mortality in all subgroups (Table). The sole exception was in women with medial tumors with ≥4 positive nodes treated with mastectomy. In this subgroup, the use of RT was associated with a 16% proportional increase in mortality. Conclusions: Medial tumor location is a significant adverse prognostic factor that should be considered in treatment decision making for women with node-positive breast cancer. Improved survival was observed with RT use in all subgroups, except in women with medial tumors and ≥4 positive nodes treated with postmastectomy RT. These findings generate the hypothesis that the favorable effect of RT may have been offset by excess toxicities in the latter subgroup with the use of large fields to encompass the internal mammary nodes. Overall Mortality Hazard Ratio (HR) with or without Radiation (RT), by Number of Nodes, Surgery, Tumor Location Overall Mortality Hazard Ratio (HR) with or without Radiation (RT), by Number of Nodes, Surgery, Tumor Location No. of positive nodes Surgery Tumor quadrant RT=no HR (95% CI) RT=yes HR (95% CI) Relative mortality reduction with RT 1–3 BCS Outer 1 (=reference) 0.87 (0.82–0.92) 13% 1-3 BCS Inner 1.35 (1.20–1.52) 1.18 (1.12–1.23) 13% 1–3 Mastectomy Outer 1.09 (1.03–1.16) 0.95 (0.94–0.96) 13% 1–3 Mastectomy Inner 1.26 (1.16–1.37) 1.10 (1.07–1.12) 13% 4+ BCS Outer 1.13 (1.07–1.20) 0.99 (0.98–0.99) 13% 4+ BCS Inner 1.53 (1.34–1.75) 1.33 (1.24–1.43) 13% 4+ Mastectomy Outer 1.24 (1.14–1.34) 1.08 (1.06–1.09) 13% 4+ Mastectomy Inner 1.25 (1.17–1.34) 1.45 (1.34–1.56) -16% HRs adjusted by registry, year, race, marital, histo, grade, receptors, age, tumor size, nodal ratio No significant financial relationships to disclose.